Physician profile
William Bruno
NPI 1720203151
$12,384.30
in general payments reported to CMS, 2019-2025
12 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,403 · 2020: $1,867 · 2021: $4,208 · 2022: $2,936 · 2023: $1,169 · 2024: $612 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,970.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $4,070.18 | 2021 | |
| Davol INC. | $3,066.54 | 2022-2023 | Phasix Mesh, Arista Ah Flexitip |
| Tepha INC | $2,811.13 | 2019-2020 | |
| Abbvie INC. | $1,009.16 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Allergan, INC. | $646.36 | 2019-2022 | |
| Motiva USA, LLC | $289.90 | 2024 | |
| Galderma Laboratories, L.P. | $204.10 | 2020-2022 | |
| Sientra, INC. | $94.34 | 2019-2020 | |
| Tela Bio, INC. | $76.50 | 2022 | |
| Revance Therapeutics, INC. | $51.12 | 2024 | Daxxify |
| Apyx Medical Corporation | $37.80 | 2020 | |
| Mentor Worldwide LLC | $27.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bruno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.